Alan P. Wimmer, MD

Alan Wimmer, M.D., is board certified in cardiology and cardiac electrophysiology and specializes in the diagnosis and treatment of heart rhythm disorders. He has a particular interest and expertise in atrial fibrillation and is a regional leader in the management of this condition.
Dr. Wimmer is the Medical Director for Arrhythmia Services for Saint Luke's Cardiovascular Consultants and Saint Luke's Mid America Heart Institute in Kansas City, Missouri and a Professor of Medicine at the University of Missouri Kansas City School of Medicine. He is part of the Ben D. McCallister Clinical Scholars Program and has published numerous peer-reviewed articles on atrial fibrillation and other topics in electrophysiology.
He received his medical degree from Duke University, was trained in internal medicine at Wilford Hall US Air Force Medical Center and completed cardiovascular diseases and clinical cardiac electrophysiology fellowships at the University of Michigan Medical Center. Dr. Wimmer enjoys solving heart-rhythm problems for his patients and teaching his skills to other cardiologists.

Peer Reviewed Publications

1. Wimmer AP, Bouffard JP, Storms PR, Pilcher JA, Chang YL, DeGuide JJ.  Primary colon cancer without gross mucosal tumor: an unusual presentation for a common malignancy.  Southern Med J 1998;91:1173-76.
2. Wimmer AP, Shapiro MJ.  The "window" of slow pathway conduction after ablation and recurrence of atrioventricular nodal reentrant tachycardia. J Interv Cardiac Electrophysiol 2002;6:51-7.
3. Durning S, Gaglione M, Moores L, Wimmer AP, Pangaro LN. Inter-site consistency as a measure of programmatic evaluation success in a medicine clerkship with multiple, geographically separated sites. Acad Med 2003;78:S36-38.
4. Denton GD, Durning SJ, Wimmer AP, Pangaro LN, Hemmer PA. Is a faculty developed pretest equivalent to pre-third year GPA or USMLE Step One as a predictor of third-year internal medicine clerkship outcomes? Teach Learn Med 2004;16:329-32.
5. Wimmer AP, Chugh A. Antitachycardia pacing during tachycardia: what is the mechanism? Heart Rhythm 2006;3:364-
6. Wimmer AP, Buerkel D, Igic P, Elmouchi D, Reich S, Tschopp D, Dey S, Good E, Jongnarangsin K, Chugh A, Bogun F, Pelosi F, Morady F. Effect of angiotensin blockade on clinical outcomes after left atrial catheter ablation for atrial fibrillation.  Hearth Rhythm (in preparation) 
7. Oral H, Chugh A, Good E, Sankaran S, Reich SS, Igic P, Elmouchi D, Tschopp D, Crawford T, Dey S, Wimmer A, Lemola K, Jongnarangsin K, Bogun F, Pelosi F Jr, Morady F. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation2006;113:1824-31.
8. Oral H, Chugh A, Mehmet Özaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F Jr, Jongnarangsin K, Bogun F, Morady F. Risk of thrombembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006;114:759-765.
9. Wimmer A, Dey S, Morady F. A non-sustained tachycardia: what is the mechanism? Heart Rhythm 2006;3:1103-04.
10. Dey S, Wimmer A, Morady F. Supraventricular tachycardia with atrioventricular block: what is the mechanism? Heart Rhythm2006;3:1236.
11. Bogun F, Good E, Reich S, Elmouchi D, Igic P, Tschopp D, Dey S, Wimmer A, Jongnarangsin K, Oral H, Chugh A, Pelosi F, Morady F: Role of Purkinje Fibers in Post-Infarction Ventricular Tachycardia.  J Am Coll Cardiol 2007;48:2498-2507.
12. Chugh A, Wimmer A, Morady F: Elimination of left superior pulmonary vein ostial potentials during radiofrequency ablation at the mitral isthumus.  Heart Rhythm 2007;4:85-87.
13. Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N, Sankaran S, Crawford T, Sarrazin J, Kuhne M, Chalfoun N, Wells D, Frederick M, Fortino J, Benloucif-Moore S, Jongnarangsin K, Pelosi F, Bogun F, Morady F. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation 2007;115:2606-12.
14. Chae S, Oral H, Good E, Dey S, Wimmer A, Crawford T, Wells D, Sarrazin JF, Chalfoun N, Kuhne M, Fortino J, Huether E, Lemerand T, Pelosi F, Bogun F, Morady F, Chugh A. Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence. J Am Coll Cardiol 2007;50:1781-7.
15. Crawford T, Wimmer A, Dey S, Chalfoun N, Wells D, Sarrazin JF, Kuhne M, Frederick M, Jongnarangsin K, Good E, Chugh A, Bogun F, Pelosi F, Morady F, Hakan O. Mechanism of recurrence after radiofrequency catheter ablation of atrial fibrillation guided by complex fractionated atrial electrograms. J Interv Cardiac Electrophysiol 2008;21:27-33.
16. Oral H, Crawford T, Frederick M, Gadeela N, Wimmer A, Dey S, Sarrazin JF, Kuhne M, Chalfoun N, Wells D, Good E, Jongnarangsin K, Chugh A, Bogun F, Pelosi F, Morady F. Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol 2008;19:466-470.
17. Cheema A, Khalid A, Wimmer A, Bartone C, Chow T, Spertus J, Chan PS. Fragmented QRS and mortality risk in patients with left ventricular dysfunction. Circ Arrhythm Electrophysiol  2010;3:339-44. 
18. Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy D, Wimmer A, Bhandari A, Burk C.  Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation. Circ Arrhythm Electrophysiol 2011;4:15-25.
19. Konduru S, Cheema A, Li Y, Jones P, Ramza B, Wimmer A. Differences in Intraprocedural ACTs with Standardized Heparin Dosing During Catheter Ablation for Atrial Fibrillation in Patients Treated with Dabigatran vs Patients on Uninterrupted Warfarin. J Interv Cardiac Electrophysiol 2012;35(3):277-284.
20. Dorian P, Burk C, Mullin C, Bubien R, Lewis S, Godejohn D, Reynolds MR, Lakkireddy D, Wimmer A, Bhandari A, Spertus J. Interpreting Changes in Quality of Life in Atrial Fibrillation: How Much Change is Clinically Meaningful? Am J Cardiol 2013;166(2):381-387.
21. Bin Abdulhak AA, Khan AR, Tleyjeh IM, Spertus JA, Sanders SU, Steigerwarlt KE, Garbati M, Reem A.Bahmaid RA, Wimmer A.  Safety and Efficacy of Interrupted Dabigatran for Periprocedural Anticoagulation in Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta-Analysis.  Europace 2013;15(10):1412-20.
22. Bin Abdulhak AA, Tleyjeh IM, Wimmer A. Dabigatran in the Setting of Catheter Ablation of Atrial Fibrillation: The Road Ahead. Heart2013;100(4)349.
23. Bin Abdulhak AA, Khan AR, Wimmer A. Dabigatran in Catheter Ablation of Atrial Fibrillation: A Call for a Randomized Control. Am J Cardiol 2014;113(12):2087-8.
24. Spooner MT, Main ML, Wimmer A. Successful Ablation of Macro-reentrant Left Atrial Tachycardia after Pulmonary Vein Isolation in a Patient with Cor Triatriatum. Heart Rhythm 2014;11(8):1487-8.
25. Al Badarin F, Wimmer A, Jacobson A, Kennedy K, Bateman T. The Utility of ADMIRE-HF Risk Score in Predicting Serious Arrhythmic Events in Heart Failure Patients: Incremental Prognostic Benefit of Cardiac 123I-mIBG Scintigraphy. J Nucl Cardiol 2014;21(4):756-62.
26. Bin Abdulhak AA, Khan AR, Wimmer A. Azithromycin use in elderly patients with pneumonia.  JAMA 2014;312(13):1352.
27. Bin Abdulhak AA, Khan AR, Garbati M, Qazi AH, Erwin P, Kisra S, Abdelrahman A, Farid T, Wimmer A. Azithromycin and risk of cardiovascular death: a meta-analytic review of observational studies. Am J  Therapeutics 2015;0(0):1-8.
28. Bin Abdulhak AA, Kennedy KF, Gupta S, Giocondo M, Ramza B, Wimmer A. Affect of preprocedural interrupted apixaban on heparin anticoagulation during catheter ablation of atrial fibrillation: a prospective observation study. J Interv Cardiac Electrophysiol2015;44(2):91-6. 
29. Qazi AH, Wimmer A, Huber KC, Latus GG, Main ML. Resolution (and late recurrence) of Watchman device-related thrombus following treatment with dabigatran. Echocardiography 2016;00:1-4.
30. Farid TA, Moser A, Austin B, Magalski A, Wimmer A. Stability of Pacing Indices and Need for Pacing in Cardiac Transplant Patients Over 1 Year of Follow-up. J Interv Cardiac Electrophysiol 2017;49(1):27-32.
31. Sharma A, Dhoot J, Wang J, Jones P, Gupta S, Wimmer A. Outcomes following cryoballoon ablation for atrial fibrillation guided by pressure waveform monitoring without the routine use of pulmonary venography. J Interv Cardiac Electrophysiol  2017;49(1):75-82.
32. Kureshi F, Bateman TM, Wimmer A. The “absent” left atrial appendage . . . Heart Rhythm Case Reports 2017;3:494–495.
33. Eschol J, Wimmer A.  Hemodynamically significant iatrogenic atrial septal defects after cryoballoon ablation.  Heart Rhythm Case Reports 2019;5(1):17-21.
34. Elkaryoni A, Al Badarin F, Khan MS, Ellakany K, Potturi N, Poonia  J, Kennedy KF, Magalski A, Sperry BW, Wimmer A. Implantable Cardioverter-Defibrillators and Survival in Advanced Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: a Systematic Review and Meta-Analysis. Europace 2019;21(9):1353-9.
35. Elkaryoni A, Al Badarin F, Khan MS, Kennedy KF, Wimmer A. Comparison of the Effect of Catheter Ablation for Atrial Fibrillation on All-Cause Hospitalization in Patients with Versus without Heart Failure (from the Nationwide Readmission Database). Am J Cardiol2020;125(3):392-8.
36. Mohammed M, Arshi J, Ramza BM, Wimmer AP, Steinhaus DA, Giocondo MJ, Gupta SK, Yousuf OK. Outcomes Using a Single Tapered Dilator for Micra Leadless Pacemaker Implant. Indian Pacing Electrophysiol J. 2020;20(3):105-11..
37. Elkaryoni A, Okasha O, Qarajeh R, Shatla I, Kennedy KF, Wimmer A. Hospitalization Rates Following Catheter Ablation for Ventricular Tachycardia in Patients: Insights from the Nationwide Readmission Database. Am J Cardiol 2020;127:196-7.
38. Gupta SK, Ya’qoub L, Wimmer AP, Fisher S, Saeed IM. Safety and Clinical Impact of  MRI in Patients with Non-MRI Conditional Cardiac Devices. Radiol Cardiothorac Imaging 2020;2(5) doi.org/10.1148/ryct.2020200086.
39. Elkaryoni A, Wimmer A. Safety and Effectiveness of Long-term Anticoagulation for Atrial Fibrillation Among Nonagenarians: A Real-world Analysis. Am J Cardiol 2021;140:151-2.
40. Mohammed M, Ramirez R, Steinhaus DA, Yousuf OK, Giocondo MJ, Ramza BM, Wimmer AP, Gupta SK.  Comparative outcomes of vascular access closure methods following atrial fibrillation/flutter catheter ablation: insights from VAscular Closure for Cardiac Ablation Registry. J Interv Cardiac Electrophysiol 2021 doi.org/10.1007/s10840-021-00981-5.
41. Shatla I, El-Zein R, Kennedy K, Elkaryoni A, Ubaid U, MD, Wimmer A. Comparison of the Safety of Left Atrial Appendage Occlusion in Patients Aged <75 versus Those Aged ≥75 Years (from a Nationwide Cohort Sample).  Am J Cardiol 2022;172:35-9.
42. Shatla I, El-Zein RS, Ubaid A, ElBallat A, Sammour Y, Kennedy KF, Barta K, Brand-Moody T, Cordle F, Williams L, Giocondo M, Gupta S, Ramza B, Steinhaus D, Yousuf O, Spertus JA, Wimmer AP. Analysis of Telehealth in the Outpatient Management of Atrial Fibrillation during the COVID-19 Pandemic.  Am J Cardiol 2023;192:174-81.
43. Shatla I, Mehta NA, Kennedy KF, Elkaryoni A, Wimmer AP. Antibacterial Envelope Use to Prevent Cardiac Implantable Device Infection: Outcomes from the National Readmission Database. J Interv Cardiac Electrophysiol 2023 doi.org/10.1007/s10840-023-01715-5.
44. Shatla I, Mehta NA, Kennedy KF, Elkaryoni A, Wimmer AP. Contemporary use of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Therapy: Insights from a Nationwide Database. Europace (under review)

Book Chapters

1.      Wimmer, AP, Oral, H.  Postprocedural care after radiofrequency catheter ablation for atrial fibrillation.  In:  Steinberg J, Calkins H, Jais P (eds), A Practical Approach to Catheter Ablation of Atrial Fibrillation.  York, PA:  Lippincott Williams & Wilkins (2008).

Abstracts and Presentations

1. Wimmer AP, Torgan CE, Campbell ME, Kraus WE.  Dihydropyridine receptor and calcium release channel messenger RNA levels in rabbit skeletal muscle following clenbuterol administration.  AOA Symposium, Duke University School of Medicine, Durham, North Carolina, April 1995.
2. Wimmer AP, Bouffard JP, Storms PR, Pilcher JA, Chang YL, DeGuide JJ.  Primary colon cancer without gross mucosal tumor: an unusual presentation for a common malignancy.  Clinical Vignette finalist, South Texas ACP Associates Program, San Antonio, Texas, May 1997.  Annual Meeting of Society of Air Force Physicians, Dayton, Ohio, March 1997.
3. Wimmer AP, Dewitt CC, Dolan MJ. Pasteurella multocida bronchitis in a patient with COPD and close contact with cats.  Clinical Vignette finalist, South Texas ACP Associates Program, San Antonio, Texas, May 1998.  Annual Meeting of  Society of Air Force Physicians, San Antonio, Texas, March 1998.
4. Rasnake MS, Wimmer AP, Farmer C. Purpura fulminans and multi-organ system failure associated with Capnocytophaga canimorsus septicemia: a case report. Annual Meeting of Society of Air Force Physicians, Berkeley, California, April 1999.
5. Wimmer AP, Shapiro ML. Persistent slow pathway conduction after ablation and risk for recurrence in av-nodal reentrant tachycardia. Annual Meeting of Society of Air Force Physicians, Berkely, California, April 1999.
6. Zarr SP, Wimmer AP, Wies K. Hyponatremia associated with exercise and heat exposure in Air Force recruits. Annual Meeting of the Society of Air Force Physicians, San Antonio, Texas, March 2000.
7. Lynch J, Fiechtner BK, Wimmer AP. Atypical lymphocytosis associated with Staphylococcus aureus abscess. Annual Meeting of the Society of Air Force Physicians, San Antonio, Texas, March 2002.
8. Fiechtner BK, Wimmer AP, DeWitt C. Pasteurella multocida infection resulting in respiratory failure: two case studies. Annual Meeting of the Society of Air Force Physicians, San Antonio, Texas, March 2002.
9. Hemmer PA, Jamieson T, Gibson K, Moores L, Donato A, Gaglione M, Durning S, Wimmer A, Cary-Freitas B, Pangaro L. Third year medical student written history and physicals: how many is “enough”? 40th Annual Conference on Research in Medical Education, Washington, D.C., November 2001.
10. Wimmer AP, Hemmer PA, Grau TC, Pangaro LN. Does counseling for students at risk for failing an end-of-clerkship examination improve their performance? 10th Ottawa Conference on Medical Education, Ottawa, Canada, July 2002.
11. Balanon, SK, Kobes PJ, Wimmer AP. Diagnosis of hereditary hemochromatosis after treatment of celiac disease.  Clinical Vignette finalist, South Texas ACP Associates Program, San Antonio, Texas, May 2003.
12. Denton GD, Pangaro LN, Wimmer AP, Durning S, Hemmer PA. Is a pre-clerkship examination equivalent to the pre-third year GPA and USMLE Step One as a predictor of performance on the third year internal medicine clerkship?  Accepted for poster presentation at SGIM in May.  Submitted to RIME and CDIM. 
13. Wimmer AP, Hemmer PA, Grau TC, Pangaro LN. Does Formative, In-clerkship Counseling of Students with Marginal Knowledge Improve Pass-Fail Performance on an End-Of-Clerkship Examination? Clerkship Directors in Medicine Annual Meeting, Savannah, Georgia, October 2003; Association for Medical Education in Europe Annual Conference, Bern, Switzerland, August 2003.
14. Wimmer AP, Denton GD, Hemmer PA, Pangaro LN. Medicine clerkship pre-test: the role of an early clerkship examination to identify clerkship students at risk of final examination failure. Clerkship Directors in Medicine Annual Meeting, Savannah, Georgia, October 2003; Association for Medical Education in Europe Annual Conference, Bern, Switzerland, August 2003.
15. Durning SJ, Pangaro LN, Denton GD, Hemmer PA, Wimmer A, Grau T, Gaglione M, Moores L. Inter-site Consistency As a Measurement of Programmatic Evaluation in a Medicine Clerkship with Multiple, Geographically Separated Sites. Presented at Northeast GEA, 2003. Presented at AMEE, 2003. Presented at RIME 2003. Award Winner, Northeast GEA Research Poster Competition
16. Durning SJ, Pangaro LN, Hemmer PA, Denton GD, Wimmer A, Grau T, Gaglione M, Moores L. What Contributes to the Variance In NBME Subject Examination Performance and Recommended Teacher Grades: A 10-year Analysis. Presented at Northeast GEA Meeting, 2003. Presented at AMEE 2003. Presented at RIME, 2003.
17. Hemmer PA, Denton GD, Durning SJ, DeZee K, Wimmer AP, Moores LK, Cuoco T, Gaglione MM, DeMott C, Heetderks P, Battistone M, Pangaro LN. Can Medical Students on a Clinical Clerkship Accurately Self-assess using a Standard, Descriptive Vocabulary? Research in Medical Education Annual Meeting, Boston MA, Nov 2004.
18. Wells D, Sankaran S, Oral H, Dey S, Wimmer A, Elmouchi D, Tschopp D, Igic P, Reich S, Good E, Jongnarangsin K, Bogun F, Pelosi F, Morady F, Chugh A: Prevelance of Fever After Left Atrial Ablation of Atrial Fibrillation.  Heart Rhythm 3:P3-69, 2006.
19. Crawford T, Chugh A, Good E, Wimmer A, Dey S, Jongnarangsin K, Pelosi Jr., F, Bogun F, Morady F, Oral H: Mechanisms of Recurrent Atrial Fibrillation After Left Atrial Radiofrequency Ablation Guided By Complex Electrograms. J Am Coll Cardiol 49(9): 32A, 2007.
20. Dorian P, Spertus J, Bubien R, Reynold M, Wimmer A, Lakkireddy D, Bhandar A, Godejohn D, Lewis S. Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation.  Atrial Fibrillation/Arrhythmias:  Epidemiology, Quality of Care, and Outcomes.  American Heart Association Annual Scientific Sessions Program.  November 15, 2010.
21. Al Badarin F, Wimmer A, Kennedy K, Bateman T. Cardiac 123I-mIBG Scintigraphy Combined with Myocardial Perfusion Imaging Identifies Heart Failure Patients at Low Risk for Serious Arrhythmic Events: Insights from ADMIRE-HF study. American College of Cardiology Annual Scientific Sessions, March 2012.
22. Konduru S, Cheema A, Li Y, Jones P, Ramza B, Wimmer A. Heparinization During Catheter Ablation for Atrial Fibrillation:  A Comparison of Patients Treated with Dabigatran vs Patients on Uninterrupted Warfarin. Heart Rhythm Society Annual Scientific Sessions, May 2012.
23. Al Badarin F, Wimmer A, Kennedy K, Bateman T. Utility of ADMIRE-HF Risk Score in Predicting Serious Arrhythmic Events in Heart Failure Patients: A Novel Application of Cardiac 123I-mIBG Scintigraphy. American Society of Nuclear Cardiology Annual Scientific Sessions, September 2012.
24. Moser A, St. Clair K, Farid T, House J, Aggarwal S, Borkon M, Wimmer A, Magalski A, Austin B. Predictors of Permanent Pacemaker Implant after Cardiac Transplantation: A Retrospective Analysis of a Contemporary Cohort. 18th Annual Scientific meeting of the Heart Failure Society of America, September 2014.
25. Bin Abdulhak AA, Kennedy K, Giocondo M, Gupta S, Ramza B, Wimmer A. Effect of Periprocedural Apixaban on Heparin Anticoagulation During Catheter Ablation for Atrial Fibrillation in Comparison to Warfarin: A Prospective Study. Heart Rhythm Society Annual Scientific Sessions, May 2015. 
26. Farid T, Moser A, Austin B, Magalski A, Wimmer A. Ongoing Need for Cardiac Pacing in a Contemporary Cohort of Orthotopic Heart Transplant Patients through One Year of Follow-up. European Heart Rhythm Association Europace – Cardiostim, June 2015.
27. Farid T, Moser A, Austin B, Magalski A, Wimmer A. Stability of Pacing Indices in Cardiac Transplant Patients.  European Heart Rhythm Association Europace – Cardiostim, June 2015.
28. YaQoub L, Price M, Kendall G, Baker T, Ansari S, Wimmer A, Gupta S, Fisher S, Saeed I. Implact of PROMeNADe- Patient Registry Of Magnetic resonance imaging in Non-Approved cardiac Devices. University of Missouri-Kansas City School of Medicine Research Day, May 2017.
29. YaQoub L, Price M, Kendall G, Baker T, Wimmer A, Ansari S, Fisher S, Gupta S, Saeed I. Impact of Magnetic Resonance Imaging in Non-Approved Cardiac Devices. Annual Scientific Sessions of the American College of Cardiology, March 2018.
30. Elkaryoni A, Al Badarin F, Khan MS, Ellakany K, Potturi K, Poonia J, Kennedy KF, Magalski A, Wimmer A. Implantable Cardioverter Defibrillators and Survival in Advanced Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: a Systematic Review and Meta-Analysis. American Heart Association Annual Scientific Sessions, November 2018.Elkaryoni A, Al Badarin F, Khan MS, Kennedy KF, Wimmer A. Catheter Ablation for Atrial Fibrillation is Followed by Lower Hospitalization Rates in Heart Failure Patients Regardless of Ejection Fraction: Insights from the Nationwide Readmission Database. American College of Cardiology Annual Scientific Sessions, March 2019.
31. Elkaryoni A, Wimmer A. Hospitalization Rates following Catheter Ablation for Ventricular Tachycardia: Insights from the Nationwide Readmission Database.  American Heart Association Annual Scientific Sessions, November 2019.
32. Barssoum K, Elkaryoni A, Muhanna A, Shatla I, Abdelkarim I, Wimmer A. Hospitalization Readmission among Anticoagulated Nonagenarians with Atrial Fibrillation: a Nationwide Cohort Sample.  American Heart Association Annual Scientific Sessions, November 2020.
33. Shatla I, Sammour Y, Kennedy KF, Wimmer AP. Impact of Telehealth in the Outpatient Management of Atrial Fibrillation during the COVID-19 Pandemic.  European Society of Cardiology Congress, August 2021.
34. Shatla I, Elkaryoni A, Abumoawad A, El Iskandarani M, Kennedy KF, Wimmer AP. Impact of Age on Hospital Outcomes Associated with Percutaneous Left Atrial Appendage Occlusion: Insights from a Nationwide Cohort Sample. American Heart Association Annual Scientific Sessions, November 2021.
35. Shatla I, Mujer M, Baker P, Kashlan B, Pieters Z, Elkaryoni A, Wimmer AP. Contemporary Trends Of Antibacterial Envelope Use To Prevent Cardiac Implantable Device Infection: Insights From The National Readmission Database. American Heart Association Annual Scientific Sessions, November 2022.
36. Shatla I, El Iskandarani M, Kennedy KF, Wimmer AP. Contemporary Trends Of Subcutaneous Implantable Cardioverter Defibrillator Utilization In The United States: Insights From The National Inpatient Sample 2016-2019. American Heart Association Annual Scientific Sessions, November 2022.
37. Mkhaimer Y, Mehta N, Mehta N, Kennedy KF, Shatla I, Wimmer AP. Clinical Outcomes Following Maze and Left Atrial Appendage Occlusion Procedures for Patients with Atrial Fibrillation Undergoing Mitral Valve Surgery: Insights from the National Readmission Database.  American Heart Association Annual Scientific Sessions, November 2023.